Single-cell spatial transcriptomics identifies SERPINE1 as a vascular endothelial mediator of cisplatin resistance in head and neck squamous cell carcinoma
Translational Oncology · 2026-12 · 74 · 103063
DOI: 10.1016/j.tranon.2026.103063 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Oncology, 2026-12. Verfasst von Hongxia Su und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rhinology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Cisplatin resistance remains a major obstacle in head and neck squamous cell carcinoma (HNSCC), yet the contribution of the vascular microenvironment and its variation across HPV statuses remains unclear. METHODS: We integrated single-cell RNA sequencing, spatial transcriptomics, and bioinformatics analyses to characterize cisplatin resistance-associated cellular states in HNSCC. Cisplatin resistance scoring, pseudotime analysis, transcriptional regulatory network analysis, and cell-cell communication analysis were used to identify resistant subpopulations. Spatial localization, survival analysis, immune infiltration assessment, and drug sensitivity prediction were further performed to evaluate key candidate genes. RESULTS: Cisplatin resistance signals were preferentially enriched in tumor endothelial cells and were stronger in HPV-negative HNSCC. Endothelial cells with high resistance scores exhibited enhanced angiogenesis, extracellular matrix remodeling, hypoxia, and inflammatory programs. Multidimensional screening identified SERPINE1 as a key resistance-associated endothelial gene, showing significant upregulation and positive correlation with resistance scores. Single-cell and spatial transcriptomic analyses consistently demonstrated vascular-associated enrichment of SERPINE1, particularly in HPV-negative tumors. High SERPINE1 expression was associated with poor survival and an immunosuppressive tumor microenvironment. Drug sensitivity prediction suggested increased sensitivity of SERPINE1-high tumors to EGFR/SRC- and MAPK-pathway inhibitors, whereas no significant differences were observed for conventional cytotoxic agents. CONCLUSION: SERPINE1 defines a tumor endothelial state associated with cisplatin resistance in HNSCC and may contribute to HPV-related differences in the vascular microenvironment, providing a potential basis for therapeutic stratification.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Rhinology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
- Department of Rhinology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China. Electronic address: zhaoyulinmailvip@163.com.
Zitieren
APA
Su, H., Zhang, Y., Wang, J., Liu, L., & Zhao, Y. (2026). Single-cell spatial transcriptomics identifies SERPINE1 as a vascular endothelial mediator of cisplatin resistance in head and neck squamous cell carcinoma. Translational Oncology, 74, 103063. https://doi.org/10.1016/j.tranon.2026.103063
Vancouver
Su H, Zhang Y, Wang J, Liu L, Zhao Y. Single-cell spatial transcriptomics identifies SERPINE1 as a vascular endothelial mediator of cisplatin resistance in head and neck squamous cell carcinoma. Translational Oncology. 2026;74:103063. doi:10.1016/j.tranon.2026.103063
BibTeX
@article{Su2026,
author = {Su, Hongxia and Zhang, Yuan and Wang, Jia and Liu, Lei and Zhao, Yulin},
title = {Single-cell spatial transcriptomics identifies SERPINE1 as a vascular endothelial mediator of cisplatin resistance in head and neck squamous cell carcinoma},
journal = {Translational Oncology},
year = {2026},
volume = {74},
pages = {103063},
doi = {10.1016/j.tranon.2026.103063}
}
EUVIMED